Showing results (591-600 of 635) with videos related to

Sort By:
Pageof 64
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 10, 2021
Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 MutationsFelix C Saalfeld, Carina Wenzel, Petros Christopoulos, et al.
NPJ Precision Oncology|October 26, 2023
NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncologyAndreas Mock, Maria-Veronica Teleanu, Simon Kreutzfeldt, et al.
European Journal of Cancer (Oxford, England : 1990)|October 18, 2024
Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapyFelix Carl Saalfeld, Johanna Möller, Petros Christopoulos, et al.
Clinical Science (London, England : 1979)|January 21, 2015
Smad7 regulates compensatory hepatocyte proliferation in damaged mouse liver and positively relates to better clinical outcome in human hepatocellular carcinomaTeng Feng, Johanna Dzieran, Xing Gu, et al.
Cell Death & Disease|October 18, 2020
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancerAnna-Lena Scherr, Andreas Mock, Georg Gdynia, et al.
Geburtshilfe Und Frauenheilkunde|June 13, 2025
COGNITION-GUIDE - Genomics-Guided Targeted Post-Neoadjuvant Therapy in Patients with Early Breast Cancer: Study Design of a Multicenter, Open-Label, Umbrella Phase II StudyConstantin Pixberg, Christian Maurer, Katharina Smetanay, et al.
The Journal of Pathology. Clinical Research|April 15, 2024
Microenvironment-induced restoration of cohesive growth associated with focal activation of P-cadherin expression in lobular breast carcinoma metastatic to the colonMalte Gronewold, Isabel Grote, Stephan Bartels, et al.
Blood|August 20, 2013
Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AMLAnuhar Chaturvedi, Michelle Maria Araujo Cruz, Nidhi Jyotsana, et al.
The Journal of Clinical Investigation|July 24, 2025
A predictive endocrine resistance index accurately stratifies luminal breast cancer treatment responders and non-respondersGuokun Zhang, Vindi Jurinovic, Stephan Bartels, et al.
Urologic Oncology|July 30, 2021
Mutations in TP53 or DNA damage repair genes define poor prognostic subgroups in primary prostate cancerCathleen Nientiedt, Jan Budczies, Volker Endris, et al.
Pageof 64